A phase 1 study of oral Debio 0123 in combination with carboplatin in patients with advanced solid tumors
Debio0123-101
Phase 1 other active
Quick answer
A phase 1 study of oral Debio 0123 in combination with carboplatin in patients with advanced solid tumors for Patients with tumors is a Phase 1 program (other) at Pharm Research Associates (UK) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharm Research Associates (UK) Limited
- Indication
- Patients with tumors
- Phase
- Phase 1
- Modality
- other
- Status
- active